Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc.

IF 0.2 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Biotechnology Law Report Pub Date : 2023-10-01 DOI:10.1089/blr.2023.29324.cip

CHRISTOPHER M. HOLMAN

{"title":"Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc.","authors":"CHRISTOPHER M. HOLMAN","doi":"10.1089/blr.2023.29324.cip","DOIUrl":null,"url":null,"abstract":"Biotechnology Law ReportAhead of Print Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc.United States Court of Appeals of the Federal Circuit, 2023 66 F.4th 1373Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMANEdited for Biotechnology Law Report by CHRISTOPHER M. HOLMANChristopher M. Holman is a Professor of Law at the University of Missouri–Kansas City School of Law; a Senior Scholar at the Center for the Protection of Intellectual Property x Innovation Policy (C-IP) at George Mason University, Antonin Scalia Law School; and the Executive Editor of Biotechnology Law Report.*The synopsis is original content and the decision itself has been condensed for ease of readability.Search for more papers by this authorPublished Online:25 Sep 2023https://doi.org/10.1089/blr.2023.29324.cipAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 0Issue 0 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN.Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc..Biotechnology Law Report.ahead of printhttp://doi.org/10.1089/blr.2023.29324.cipOnline Ahead of Print:September 25, 2023PDF download","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":"33 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Law Report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/blr.2023.29324.cip","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 1

Abstract

Biotechnology Law ReportAhead of Print Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc.United States Court of Appeals of the Federal Circuit, 2023 66 F.4th 1373Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMANEdited for Biotechnology Law Report by CHRISTOPHER M. HOLMANChristopher M. Holman is a Professor of Law at the University of Missouri–Kansas City School of Law; a Senior Scholar at the Center for the Protection of Intellectual Property x Innovation Policy (C-IP) at George Mason University, Antonin Scalia Law School; and the Executive Editor of Biotechnology Law Report.*The synopsis is original content and the decision itself has been condensed for ease of readability.Search for more papers by this authorPublished Online:25 Sep 2023https://doi.org/10.1089/blr.2023.29324.cipAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 0Issue 0 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN.Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc..Biotechnology Law Report.ahead of printhttp://doi.org/10.1089/blr.2023.29324.cipOnline Ahead of Print:September 25, 2023PDF download

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

赛诺菲-安万特德国有限公司诉迈兰制药案。公司。

赛诺菲-安万特德国有限公司诉迈兰制药前生物技术法律报告。CHRISTOPHER M. Holman是密苏里-堪萨斯城大学法学院的法学教授;乔治梅森大学安东宁·斯卡利亚法学院知识产权保护与创新政策中心(C-IP)高级学者;也是《生物技术法律报告》的执行主编。*摘要是原创内容，为了便于阅读，决定本身已被浓缩。搜索本文作者的更多论文出版在线:2023年9月25日https://doi.org/10.1089/blr.2023.29324.cipAboutSectionsView文章查看全文pdf /EPUB权限和引文下载CitationsTrack引文添加到收藏回到出版物共享分享在facebook上推特链接在redditemail查看文章figuresreferencesrelateddetails卷0发行0信息版权2023,Mary Ann Liebert, Inc.，出版商引用这篇文章:编辑为生物技术法律报告由CHRISTOPHER M. HOLMAN。赛诺菲-安万特德国有限公司诉迈兰制药案。生物技术法律报告。打印前://doi.org/10.1089/blr.2023.29324.cipOnline打印前:2023年9月25日pdf下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Biotechnology Law Report 工程技术-生物工程与应用微生物

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： The leading authoritative journal since 1982 devoted to the evolving body of law and government regulation concerning biotechnology, particularly in the industries in which new products from these technologies are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. All legal aspects are rapidly reported, and critical and often hard-to-obtain documents are reproduced.